Professor Xueyuan Guo
Beijing AnZhen Hospital affiliated to Capital Medical University, Beijing (China)
Membership:
FESC Member
Follow
Contributor content
Journal
Clinical outcomes of edoxaban treatment in atrial fibrillation patients with high bleeding risk: insights from the ETNA-AF-China 1-year follow-up
28 October 2024
Journal
One-year effectiveness and safety outcomes of edoxaban treatment in Chinese patients with atrial fibrillation: First snapshot of more than 4,800 patients from the ETNA-AF-China study
24 May 2024
